2020 CCHF Industry Symposium
May 23, 2020
Gene therapy. Will it be everything we’ve hoped and prayed for? Will it work for everyone? How soon will we know? Questions and rumors abound. What’s real and what’s not?
Central California Hemophilia Foundation and Takeda Pharmaceutical Company invite you to join us for the 2020 Industry Symposium online Saturday, May 23rd, to hear answers to those and other questions from one of the nation’s leading experts, Dr. Steven Pipe. A University of Michigan professor and researcher, Dr. Pipe is a member of the National Hemophilia Foundation Board of Directors and chair of NHF’s Medical & Scientific Advisory Council. Dr. Pipe’s keynote presentation will be one of eight educational sessions during this free virtual event that will enable us to bring important information to the bleeding disorders community despite the current restrictions on large group events because of COVID-19 concerns.
There will also be sessions on stress management, alternative forms of pain management, and other important topics. There will even be a “community room” where people can briefly visit with friends they haven’t seen since social distancing began. And since you can’t actually come to the Symposium, we’ll send the symposium to you. Register by Friday, May 15th, and we will ship you a box filled with informational materials, all the goodies you’d have picked up from exhibitor tables and a surprise or two. So, don’t wait! Register right now at:
We know that this time is hard, scary and emotional.
We are still here to help.
Here at CCHF we have put together some resources and have been keeping up to the second on what our government is doing. If you feel like you need more than what you can find on the internet, please do not hesitate to call.
The Central California Hemophilia Foundation is dedicated to improving the quality of care and life for persons impacted by inherited bleeding disorders through education, advocacy and support.
Attend an Upcoming Meeting or Event!
Check out our Calendar of Events.